Cantor Fitzgerald Weighs in on CVS Health Corp’s FY2018 Earnings (CVS)

CVS Health Corp (NYSE:CVS) – Equities research analysts at Cantor Fitzgerald issued their FY2018 EPS estimates for shares of CVS Health in a research report issued to clients and investors on Tuesday, November 27th. Cantor Fitzgerald analyst S. Halper expects that the pharmacy operator will post earnings of $7.05 per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $96.00 price target on the stock. Cantor Fitzgerald also issued estimates for CVS Health’s FY2019 earnings at $7.60 EPS.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 EPS for the quarter, beating the consensus estimate of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The business had revenue of $47.27 billion during the quarter, compared to analyst estimates of $47.22 billion. During the same quarter in the previous year, the business posted $1.50 EPS. The company’s quarterly revenue was up 2.4% compared to the same quarter last year.

Other research analysts have also issued research reports about the stock. Bank of America boosted their price objective on shares of CVS Health from $86.00 to $90.00 and gave the stock a “buy” rating in a research note on Monday, September 17th. Royal Bank of Canada reiterated a “buy” rating and set a $90.00 price objective on shares of CVS Health in a research note on Wednesday, August 8th. Tigress Financial reiterated a “buy” rating on shares of CVS Health in a research note on Friday, October 26th. Morgan Stanley set a $100.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a research note on Wednesday, November 7th. Finally, Argus boosted their price objective on shares of CVS Health to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 13th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. CVS Health has an average rating of “Buy” and an average price target of $90.83.

NYSE CVS opened at $80.00 on Friday. The company has a debt-to-equity ratio of 1.66, a current ratio of 2.44 and a quick ratio of 1.94. The company has a market cap of $81.78 billion, a P/E ratio of 13.56, a PEG ratio of 1.15 and a beta of 0.98. CVS Health has a 52 week low of $60.14 and a 52 week high of $83.88.

The business also recently declared a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.50%. CVS Health’s payout ratio is 33.90%.

In other CVS Health news, EVP Eva C. Boratto sold 13,311 shares of the company’s stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $77.16, for a total transaction of $1,027,076.76. Following the transaction, the executive vice president now owns 55,162 shares in the company, valued at approximately $4,256,299.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Troyen A. Brennan sold 14,229 shares of the company’s stock in a transaction that occurred on Wednesday, November 14th. The shares were sold at an average price of $82.00, for a total transaction of $1,166,778.00. The disclosure for this sale can be found here. Insiders have sold a total of 49,074 shares of company stock worth $3,916,575 in the last 90 days. 0.53% of the stock is currently owned by company insiders.

A number of institutional investors have recently modified their holdings of the business. Camarda Financial Advisors LLC purchased a new stake in shares of CVS Health in the 2nd quarter valued at $102,000. Canton Hathaway LLC purchased a new stake in shares of CVS Health in the 3rd quarter valued at $126,000. MCF Advisors LLC boosted its holdings in shares of CVS Health by 284.1% in the 3rd quarter. MCF Advisors LLC now owns 1,713 shares of the pharmacy operator’s stock valued at $135,000 after acquiring an additional 1,267 shares during the last quarter. Capital Guardian Trust Co. purchased a new stake in shares of CVS Health in the 3rd quarter valued at $142,000. Finally, Patten Group Inc. boosted its holdings in shares of CVS Health by 163.4% in the 3rd quarter. Patten Group Inc. now owns 1,844 shares of the pharmacy operator’s stock valued at $145,000 after acquiring an additional 1,144 shares during the last quarter. Institutional investors and hedge funds own 83.03% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Article: What is Liquidity?

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply